These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 33897066)

  • 1. Adverse Effects of Recreational and Medical Cannabis.
    Urits I; Charipova K; Gress K; Li N; Berger AA; Cornett EM; Kassem H; Ngo AL; Kaye AD; Viswanath O
    Psychopharmacol Bull; 2021 Jan; 51(1):94-109. PubMed ID: 33897066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
    Breijyeh Z; Jubeh B; Bufo SA; Karaman R; Scrano L
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and neuropsychiatry, 1: benefits and risks.
    Andrade C
    J Clin Psychiatry; 2016 May; 77(5):e551-4. PubMed ID: 27249079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Short-and long-term effects of cannabinoids on memory, cognition and mental illness].
    Sagie S; Eliasi Y; Livneh I; Bart Y; Monovich E
    Harefuah; 2013 Dec; 152(12):737-41, 751. PubMed ID: 24483000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis Use and its Association with Psychological Disorders.
    Urits I; Gress K; Charipova K; Li N; Berger AA; Cornett EM; Hasoon J; Kassem H; Kaye AD; Viswanath O
    Psychopharmacol Bull; 2020 May; 50(2):56-67. PubMed ID: 32508368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review.
    Broyd SJ; van Hell HH; Beale C; Yücel M; Solowij N
    Biol Psychiatry; 2016 Apr; 79(7):557-67. PubMed ID: 26858214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Cannabis Use and Cognitive Reserves and Hippocampal Volume in Midlife.
    Meier MH; Caspi A; R Knodt A; Hall W; Ambler A; Harrington H; Hogan S; M Houts R; Poulton R; Ramrakha S; Hariri AR; Moffitt TE
    Am J Psychiatry; 2022 May; 179(5):362-374. PubMed ID: 35255711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.
    Panlilio LV; Justinova Z
    Neuropsychopharmacology; 2018 Jan; 43(1):116-141. PubMed ID: 28845848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence.
    Hanson KL; Winward JL; Schweinsburg AD; Medina KL; Brown SA; Tapert SF
    Addict Behav; 2010 Nov; 35(11):970-6. PubMed ID: 20621421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical cannabis: Critical points for clinical application.
    Gómez-García DM; García-Perdomo HA
    Biomedica; 2022 Sep; 42(3):450-459. PubMed ID: 36122285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis and Cannabinoids for Chronic Pain.
    Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
    Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Changing Drug Culture: Medical and Recreational Marijuana.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():11-7. PubMed ID: 26881768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users.
    Weinstein A; Livny A; Weizman A
    Curr Pharm Des; 2016; 22(42):6366-6379. PubMed ID: 27549374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cognitive abnormalities and cannabis use].
    Solowij N; Pesa N
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S31-40. PubMed ID: 20512268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
    Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
    BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive and Negative Effects of Cannabis and Cannabinoids on Health.
    Cohen K; Weizman A; Weinstein A
    Clin Pharmacol Ther; 2019 May; 105(5):1139-1147. PubMed ID: 30703255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of synthetic cannabinoids on executive function.
    Cohen K; Kapitány-Fövény M; Mama Y; Arieli M; Rosca P; Demetrovics Z; Weinstein A
    Psychopharmacology (Berl); 2017 Apr; 234(7):1121-1134. PubMed ID: 28160034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies.
    Cooper ZD; Abrams DI
    Am J Drug Alcohol Abuse; 2019; 45(6):580-595. PubMed ID: 31687845
    [No Abstract]   [Full Text] [Related]  

  • 20. Risks and Benefits of Cannabis and Cannabinoids in Psychiatry.
    Hill KP; Gold MS; Nemeroff CB; McDonald W; Grzenda A; Widge AS; Rodriguez C; Kraguljac NV; Krystal JH; Carpenter LL
    Am J Psychiatry; 2022 Feb; 179(2):98-109. PubMed ID: 34875873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.